These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 33930041

  • 1. Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
    Rickmann A, Paez LR, Della Volpe Waizel M, Bisorca-Gassendorf L, Schulz A, Vandebroek AC, Szurman P, Januschowski K.
    PLoS One; 2021; 16(4):e0250587. PubMed ID: 33930041
    [Abstract] [Full Text] [Related]

  • 2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results (French translation of the article)].
    Boiché M, Angioi-Duprez K, Conart JB, Berrod JP.
    J Fr Ophtalmol; 2020 Jan; 43(1):43-50. PubMed ID: 31870667
    [Abstract] [Full Text] [Related]

  • 5. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 6. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 7. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F, Klatt C, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [Abstract] [Full Text] [Related]

  • 8. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P.
    Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
    Abboud M, Benzerroug M, Milazzo S.
    J Fr Ophtalmol; 2017 Feb; 40(2):133-137. PubMed ID: 28189348
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Vitrectomy Combined with Subretinal rtPA Injection with Gas or Air Tamponade.
    Waizel M, Todorova MG, Rickmann A, Blanke BR, Szurman P.
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):487-492. PubMed ID: 28142164
    [Abstract] [Full Text] [Related]

  • 11. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, Tsang KK, Chen LJ, Brelen M, Lai TYY.
    Ophthalmologica; 2024 Apr; 247(2):118-132. PubMed ID: 38408445
    [Abstract] [Full Text] [Related]

  • 12. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R, Guthoff T, Meigen T, Goebel W.
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [Abstract] [Full Text] [Related]

  • 13. [Subretinal co-application of rtPA and bevacizumab for exudative AMD with submacular hemorrhage. Compatibility and clinical long-term results].
    Hillenkamp J, Klettner A, Puls S, Treumer F, Roider J.
    Ophthalmologe; 2012 Jul; 109(7):648-56. PubMed ID: 22752624
    [Abstract] [Full Text] [Related]

  • 14. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT, Sjaarda RN.
    Trans Am Ophthalmol Soc; 2005 Jul; 103():98-107; discussion 107. PubMed ID: 17057793
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of submacular hematoma by vitrectomy, subretinal injection of rtPA and gaseous tamponade: A single-center retrospective observational study].
    Berthon C, Rousseau E, Chiambaretta F.
    J Fr Ophtalmol; 2020 May; 43(5):417-426. PubMed ID: 32192752
    [Abstract] [Full Text] [Related]

  • 16. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

  • 17. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH.
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 19. Vitrectomy with subretinal tissue plasminogen activator (r-TPA) and intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) for submacular hemorrhages treatment: Retrospective analysis of 22 cases.
    Herranz Cabarcos A, Quiroz Quiroga MJ, Alarcón Valero I, Castilla Martí M, Pospoki V, Vilaplana Blanch D.
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jul; 97(7):391-395. PubMed ID: 35779895
    [Abstract] [Full Text] [Related]

  • 20. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M, Karabaş VL, Aslan MS, Kara Ö, Karaman S, Yenihayat F.
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.